Folic acid therapy in the fragile X syndrome.
Two brothers with fra(X) positive X-linked mental retardation (XLMR) were treated with folic acid. Initially a double blind cross-over design was employed followed by a long-term high dose trial. A decrease in the frequency of fra(X) positive cells was observed when low folic acid culture medium was used but not when an FUdR induction system was employed. Selected behavioral characteristics improved in both while receiving folic acid. Decreased hyperactivity, greater attention span, increased motor coordination, increased quantity and quality of speech were noted. Improvement in Leiter mental age and regression after cessation of treatment was seen in one subject but not in the other. Further controlled trials with larger numbers of subjects using high doses of folic acid over longer periods of time are needed to assess the possible benefits of this experimental form of treatment.
D000293:Adolescent; D002648:Child; D002873:Chromosome Fragility / Q000187:drug effects; D005492:Folic Acid / Q000097:blood / Q000627:therapeutic use*; D005600:Fragile X Syndrome / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D007361:Intelligence Tests; D008297:Male; D012729:Sex Chromosome Aberrations / Q000188:drug therapy*
D005492:Folic Acid